CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc., Salt Lake City, Utah, USA has developed a diagnostic kit for COVID-19, which already has approval from the US Food and Drug Administration (FDA). In India, the firm has received a research test licence from the Central Drugs Standard Control Organisation (CDSCO) and is in the process of obtaining a fullfledged manufacturing licence.